Market research
MXC.AU MGC Pharmaceuticals Limited
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Community
Investor discussion
1 comment
Sign in to join the MXC.AU discussion.
5 years, 5 months ago
MGC Pharmaceuticals Limited is currently in a long term downtrend where the price is trading 10.3% below its 200 day moving average.
From a valuation standpoint, the stock is 65.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 90.1.
MGC Pharmaceuticals Limited's total revenue sank by 58.3% to $745K since the same quarter in the previous year.
Its net income has increased by 47.5% to $-6M since the same quarter in the previous year.
Finally, its free cash flow fell by 15.1% to $-4M since the same quarter in the previous year.
Based on the above factors, MGC Pharmaceuticals Limited gets an overall score of 2/5.